Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
3.12M
-
Number of holders
-
98
-
Total 13F shares, excl. options
-
39M
-
Shares change
-
-491K
-
Total reported value, excl. options
-
$516M
-
Value change
-
-$7.52M
-
Number of buys
-
61
-
Number of sells
-
-24
-
Price
-
$13.24
Significant Holders of Passage BIO, Inc. - COMMON STOCK (PASG) as of Q2 2021
107 filings reported holding PASG - Passage BIO, Inc. - COMMON STOCK as of Q2 2021.
Passage BIO, Inc. - COMMON STOCK (PASG) has 98 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39M shares
.
Largest 10 shareholders include ORBIMED ADVISORS LLC (6.96M shares), FMR LLC (6.56M shares), FRAZIER MANAGEMENT LLC (5.01M shares), Versant Venture Management, LLC (4.96M shares), BOXER CAPITAL, LLC (1.93M shares), VANGUARD GROUP INC (1.86M shares), STATE STREET CORP (1.83M shares), MORGAN STANLEY (1.15M shares), HIGHLINE CAPITAL MANAGEMENT, L.P. (998K shares), and JPMORGAN CHASE & CO (770K shares).
This table shows the top 98 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.